With the emergence and long-term Impact of COVID-19, Global Perinatal Infections Market to reach USD XXX Million by 2030
Bizwit Research & Consulting LLP’s recent analysis on the Global Perinatal Infections Market points towards a potential rise to USD XXX Million by 2030. Perinatal infections are infections that occur during pregnancy or shortly after delivery, which can be transmitted from the mother to the fetus or newborn. These infections is generally caused by bacteria, viruses, fungi, or parasites that exhibit a serious impact on both the mother and the infant.
Several common perinatal infections include cytomegalovirus infection, enterovirus infection, genital herpes, gonorrhea, human immunodeficiency virus, others. The surging cases of perinatal infections, growing awareness regarding treatment availability, rising number of government initiatives, spurring demand for personalized medicine, rising inclination towards point-of-care testing are the most prominent factors that are propelling the market demand across the globe.
Geographically, the global Perinatal Infections market has been segmented into North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa (MEA). North America dominated the market in 2022 owing to the increasing preference towards point-of-care testing, rising number of government initiatives, and spurring demand for personalized medicine. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecasting years. The surging cases of perinatal infections, growing awareness regarding treatment availability, increasing demand for retail pharmacies, and rising healthcare spending are significantly propelling the market demand across the region.
The global Perinatal Infections market is highly competitive owing to the presence of several key players such as Merck KGaA (Germany) Beckman Coulter Inc. (U.S.) BIOMERIEUX (France) Bio-Rad Laboratories, Inc (U.S.) Danaher (U.S.) Hologic Inc. (U.S.) Gilead Sciences, Inc. (U.S.) Emcure Pharmaceuticals Limited. (India) Cipla Inc. (U.S.) Johnson & Johnson Private Limited (U.S.), and others.
For further analysis on this or to request a sample copy of this report, please click the link mentioned below:
Key findings of the study suggest:
- Global Perinatal Infections Market is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2023-2030.
- In the Infection Type segment, Cytomegalovirus Infection emerged out as the leading market segment in 2022.
- North America is anticipated to drive regional growth owing to the increasing preference towards point-of-care testing, rising number of government initiatives, and spurring demand for personalized medicine.
- Asia Pacific is expected to grow at higher rate followed by Europe during 2023-2030.
Bizwit Research & Consulting has considered following segments for the study:
By Infection Type:
- Cytomegalovirus Infection
- Enterovirus Infection
- Genital Herpes
- Gonorrhoea
- Human Immunodeficiency Virus
- Others
By Diagnosis:
- Maternal Test
- Neonatal Test
- Others
By Treatment:
- Antibiotics
- Antiviral
- Antiretroviral
- Others
By Route of Administration:
- Oral
- Parenteral
- Others
By End-user:
- Hospitals
- Homecare
- Specialty Clinics
Regional Outlook
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Korea
- Australia
- RoAPAC
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
To get a sample of this report or to purchase a copy of the study, you can directly contact us at: sales@bizwitresearch.com
About Us
Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. The company has a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. Bizwit incorporate big data, expert analysis, and huge industry database to deliver client focused business consulting reports. Our analysts perform unbiased measurement and assessment of market opportunities to comprehend detailed market forecast. Our team of key opinion leaders evaluates the market size, growth prospects, end-use, applications, value & supply chain and top vendors in the industry to help the clients to take conversant business decisions without any vague assumptions.
Contact US
Global Business Development
Phone: +1 209 498-3066
Email: Sales@bizwitresearch.com
Website: www.bizwitresearch.com
